ALIGN TECHNOLOGY, INC. Income Tax Expense
ALIGN TECHNOLOGY, INC. (ALGN) reported Income Tax Expense of $40.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $40.40M, a 17.40% decline year-over-year.
- ALIGN TECHNOLOGY, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $36.12M, a 23.50% decline year-over-year.
- ALIGN TECHNOLOGY, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $40.84M, a 10.45% increase year-over-year.
- ALIGN TECHNOLOGY, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $37.98M, a 23.99% decline year-over-year.
- ALIGN TECHNOLOGY, INC. income tax expense (benefit) for fiscal 2025 was $174.94M, a 6.75% decline from fiscal 2024.
- ALIGN TECHNOLOGY, INC. income tax expense (benefit) for fiscal 2024 was $187.60M, a 4.36% decline from fiscal 2023.
- ALIGN TECHNOLOGY, INC. income tax expense (benefit) for fiscal 2023 was $196.15M, a 17.40% decline from fiscal 2022.
- ALIGN TECHNOLOGY, INC. income tax expense (benefit) for fiscal 2022 was $237.48M, a 1.21% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $40.40M 10-Q · filed 2026-08-05 | $76.51M 10-Q · filed 2026-08-05 | $117.35M derived: sum of 3 quarters · filed 2026-08-05 | $155.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $36.12M 10-Q · filed 2026-05-06 | $76.95M derived: sum of 2 quarters · filed 2026-05-06 | $114.93M derived: sum of 3 quarters · filed 2026-05-06 | $163.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $40.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $78.82M derived: sum of 2 quarters · filed 2026-02-27 | $127.72M derived: sum of 3 quarters · filed 2026-08-05 | $174.94M 10-K · filed 2026-02-27 |
| 2025-09-30 | $37.98M 10-Q · filed 2025-11-05 | $86.89M derived: sum of 2 quarters · filed 2026-08-05 | $134.10M 10-Q · filed 2025-11-05 | $171.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $48.91M 10-Q · filed 2026-08-05 | $96.12M 10-Q · filed 2026-08-05 | $133.09M derived: sum of 3 quarters · filed 2026-08-05 | $183.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $47.21M 10-Q · filed 2026-05-06 | $84.18M derived: sum of 2 quarters · filed 2026-05-06 | $134.15M derived: sum of 3 quarters · filed 2026-05-06 | $181.45M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $36.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $86.94M derived: sum of 2 quarters · filed 2026-02-27 | $134.24M derived: sum of 3 quarters · filed 2026-02-27 | $187.60M 10-K · filed 2026-02-27 |
| 2024-09-30 | $49.97M 10-Q · filed 2025-11-05 | $97.27M derived: sum of 2 quarters · filed 2025-11-05 | $150.63M 10-Q · filed 2025-11-05 | $199.49M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $47.30M 10-Q · filed 2025-08-06 | $100.66M 10-Q · filed 2025-08-06 | $149.53M derived: sum of 3 quarters · filed 2026-02-27 | $190.21M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $53.36M 10-Q · filed 2025-05-08 | $102.22M derived: sum of 2 quarters · filed 2026-02-27 | $142.91M derived: sum of 3 quarters · filed 2026-02-27 | $202.68M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $48.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $89.55M derived: sum of 2 quarters · filed 2026-02-27 | $149.32M derived: sum of 3 quarters · filed 2026-02-27 | $196.15M 10-K · filed 2026-02-27 |
| 2023-09-30 | $40.68M 10-Q · filed 2024-11-05 | $100.46M derived: sum of 2 quarters · filed 2024-11-05 | $147.28M 10-Q · filed 2024-11-05 | $220.83M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $59.77M 10-Q · filed 2024-08-02 | $106.60M 10-Q · filed 2024-08-02 | $180.15M derived: sum of 3 quarters · filed 2025-02-28 | $230.09M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $46.83M 10-Q · filed 2024-05-03 | $120.37M derived: sum of 2 quarters · filed 2025-02-28 | $170.31M derived: sum of 3 quarters · filed 2025-02-28 | $231.12M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $73.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $123.49M derived: sum of 2 quarters · filed 2025-02-28 | $184.30M derived: sum of 3 quarters · filed 2025-02-28 | $237.48M 10-K · filed 2025-02-28 |
| 2022-09-30 | $49.94M 10-Q · filed 2023-11-03 | $110.75M derived: sum of 2 quarters · filed 2023-11-03 | $163.94M 10-Q · filed 2023-11-03 | $192.99M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $60.81M 10-Q · filed 2023-08-04 | $114.00M 10-Q · filed 2023-08-04 | $143.05M derived: sum of 3 quarters · filed 2024-02-28 | $224.07M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $53.19M 10-Q · filed 2023-05-05 | $82.24M derived: sum of 2 quarters · filed 2024-02-28 | $163.26M derived: sum of 3 quarters · filed 2024-02-28 | $232.35M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $29.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $110.07M derived: sum of 2 quarters · filed 2024-02-28 | $179.16M derived: sum of 3 quarters · filed 2024-02-28 | $240.40M 10-K · filed 2024-02-28 |
| 2021-09-30 | $81.02M 10-Q · filed 2022-11-04 | $150.11M derived: sum of 2 quarters · filed 2022-11-04 | $211.35M 10-Q · filed 2022-11-04 | $266.91M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $69.09M 10-Q · filed 2022-08-04 | $130.33M 10-Q · filed 2022-08-04 | $185.89M derived: sum of 3 quarters · filed 2023-02-27 | $231.06M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $61.24M 10-Q · filed 2022-05-05 | $116.80M derived: sum of 2 quarters · filed 2023-02-27 | $161.97M derived: sum of 3 quarters · filed 2023-02-27 | $129.08M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $55.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $100.73M derived: sum of 2 quarters · filed 2023-02-27 | $67.84M derived: sum of 3 quarters · filed 2023-02-27 | -$1.40B 10-K · filed 2023-02-27 |
| 2020-09-30 | $45.17M 10-Q · filed 2021-11-02 | $12.28M derived: sum of 2 quarters · filed 2021-11-02 | -$1.45B 10-Q · filed 2021-11-02 | -$1.42B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$32.89M 10-Q · filed 2021-08-04 | -$1.50B 10-Q · filed 2021-08-04 | -$1.46B derived: sum of 3 quarters · filed 2022-02-25 | -$1.44B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$1.46B 10-Q · filed 2021-05-05 | -$1.43B derived: sum of 2 quarters · filed 2022-02-25 | -$1.40B derived: sum of 3 quarters · filed 2022-02-25 | -$1.36B derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $34.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $60.43M derived: sum of 2 quarters · filed 2022-02-25 | $103.55M derived: sum of 3 quarters · filed 2022-02-25 | $112.35M 10-K · filed 2022-02-25 |
| 2019-09-30 | $25.89M 10-Q · filed 2020-10-30 | $69.02M derived: sum of 2 quarters · filed 2020-10-30 | $77.81M 10-Q · filed 2020-10-30 | $100.33M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $43.12M 10-Q · filed 2020-07-31 | $51.92M 10-Q · filed 2020-07-31 | $74.43M derived: sum of 3 quarters · filed 2021-02-26 | $99.03M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $8.80M 10-Q · filed 2020-05-05 | $31.31M derived: sum of 2 quarters · filed 2021-02-26 | $55.91M derived: sum of 3 quarters · filed 2021-02-26 | $63.62M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $22.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $47.12M derived: sum of 2 quarters · filed 2021-02-26 | $54.82M derived: sum of 3 quarters · filed 2021-02-26 | $57.72M 10-K · filed 2021-02-26 |
| 2018-09-30 | $24.60M 10-Q · filed 2019-10-31 | $32.30M derived: sum of 2 quarters · filed 2019-10-31 | $35.21M 10-Q · filed 2019-10-31 | $138.86M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $7.70M 10-Q · filed 2019-08-01 | $10.61M 10-Q · filed 2019-08-01 | $114.26M derived: sum of 3 quarters · filed 2020-02-28 | $132.60M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $2.90M 10-Q · filed 2019-05-02 | $106.56M derived: sum of 2 quarters · filed 2020-02-28 | $124.90M derived: sum of 3 quarters · filed 2020-02-28 | $140.29M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $103.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $122.00M derived: sum of 2 quarters · filed 2020-02-28 | $137.38M derived: sum of 3 quarters · filed 2020-02-28 | $130.16M 10-K · filed 2020-02-28 |
| 2017-09-30 | $18.34M 10-Q · filed 2018-11-01 | $33.73M derived: sum of 2 quarters · filed 2018-11-01 | $26.51M 10-Q · filed 2018-11-01 | $38.54M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $15.39M 10-Q · filed 2018-08-02 | $8.16M 10-Q · filed 2018-08-02 | $20.19M derived: sum of 3 quarters · filed 2019-02-28 | $31.89M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$7.22M 10-Q · filed 2018-05-03 | $4.80M derived: sum of 2 quarters · filed 2019-02-28 | $16.50M derived: sum of 3 quarters · filed 2019-02-28 | $31.62M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $12.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $23.73M derived: sum of 2 quarters · filed 2019-02-28 | $38.84M derived: sum of 3 quarters · filed 2019-02-28 | $51.20M 10-K · filed 2019-02-28 |
| 2016-09-30 | $11.70M 10-Q · filed 2017-11-02 | $26.81M derived: sum of 2 quarters · filed 2017-11-02 | $39.17M 10-Q · filed 2017-11-02 | $49.95M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $15.11M 10-Q · filed 2017-08-03 | $27.47M 10-Q · filed 2017-08-03 | $38.25M derived: sum of 3 quarters · filed 2018-02-28 | $47.11M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $12.36M 10-Q · filed 2017-05-04 | $23.14M derived: sum of 2 quarters · filed 2018-02-28 | $32.00M derived: sum of 3 quarters · filed 2018-02-28 | $43.15M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $10.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $19.64M derived: sum of 2 quarters · filed 2018-02-28 | $30.79M derived: sum of 3 quarters · filed 2018-02-28 | $42.08M 10-K · filed 2018-02-28 |
| 2015-09-30 | $8.86M 10-Q · filed 2016-11-08 | $20.01M derived: sum of 2 quarters · filed 2016-11-08 | $31.31M 10-Q · filed 2016-11-08 | $41.54M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $11.15M 10-Q · filed 2016-08-04 | $22.44M 10-Q · filed 2016-08-04 | $32.68M derived: sum of 3 quarters · filed 2017-02-28 | $43.98M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $11.29M 10-Q · filed 2016-05-05 | $21.53M derived: sum of 2 quarters · filed 2017-02-28 | $32.83M derived: sum of 3 quarters · filed 2017-02-28 | $45.87M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $10.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $21.54M derived: sum of 2 quarters · filed 2017-02-28 | $34.58M derived: sum of 3 quarters · filed 2017-02-28 | $44.54M 10-K · filed 2017-02-28 |
| 2014-09-30 | $11.30M 10-Q · filed 2015-10-29 | $24.34M derived: sum of 2 quarters · filed 2015-10-29 | $34.30M 10-Q · filed 2015-10-29 | $44.60M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $13.04M 10-Q · filed 2015-07-30 | $23.00M 10-Q · filed 2015-07-30 | $33.30M derived: sum of 3 quarters · filed 2016-02-25 | $40.68M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $9.96M 10-Q · filed 2015-05-01 | $20.26M derived: sum of 2 quarters · filed 2016-02-25 | $27.64M derived: sum of 3 quarters · filed 2016-02-25 | $35.88M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $17.68M derived: sum of 2 quarters · filed 2016-02-25 | $25.92M derived: sum of 3 quarters · filed 2016-02-25 | $28.84M 10-K · filed 2016-02-25 |
| 2013-09-30 | $7.38M 10-Q · filed 2014-10-30 | $15.62M derived: sum of 2 quarters · filed 2014-10-30 | $18.54M 10-Q · filed 2014-10-30 | $25.38M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $8.25M 10-Q · filed 2014-07-31 | $11.17M 10-Q · filed 2014-07-31 | $18.01M derived: sum of 3 quarters · filed 2015-02-26 | $22.50M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $2.92M 10-Q · filed 2014-05-01 | $9.76M derived: sum of 2 quarters · filed 2015-02-26 | $14.25M derived: sum of 3 quarters · filed 2015-02-26 | $22.32M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $11.33M derived: sum of 2 quarters · filed 2015-02-26 | $19.39M derived: sum of 3 quarters · filed 2015-02-26 | $25.61M 10-K · filed 2015-02-26 |
| 2012-09-30 | $4.49M 10-Q · filed 2013-11-01 | $12.55M derived: sum of 2 quarters · filed 2013-11-01 | $18.77M 10-Q · filed 2013-11-01 | $24.66M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $8.06M 10-Q · filed 2013-08-02 | $14.27M 10-Q · filed 2013-08-02 | $20.17M derived: sum of 3 quarters · filed 2014-02-28 | $27.10M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $6.21M 10-Q · filed 2013-05-03 | $12.11M derived: sum of 2 quarters · filed 2014-02-28 | $19.04M derived: sum of 3 quarters · filed 2014-02-28 | $24.16M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $12.83M derived: sum of 2 quarters · filed 2014-02-28 | $17.95M derived: sum of 3 quarters · filed 2014-02-28 | $23.23M 10-K · filed 2014-02-28 |
| 2011-09-30 | $6.93M 10-Q · filed 2012-11-09 | $12.06M derived: sum of 2 quarters · filed 2012-11-09 | $17.33M 10-Q · filed 2012-11-09 | $21.94M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $5.13M 10-Q · filed 2012-08-02 | $10.40M 10-Q · filed 2012-08-02 | $15.01M derived: sum of 3 quarters · filed 2013-03-01 | $20.04M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $5.27M 10-Q · filed 2012-05-08 | $9.88M derived: sum of 2 quarters · filed 2013-03-01 | $14.91M derived: sum of 3 quarters · filed 2013-03-01 | $27.81M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $9.64M derived: sum of 2 quarters · filed 2013-03-01 | $22.54M derived: sum of 3 quarters · filed 2013-03-01 | $27.75M 10-K · filed 2013-03-01 |
| 2010-09-30 | $5.03M 10-Q · filed 2011-11-04 | $17.92M derived: sum of 2 quarters · filed 2011-11-04 | $23.14M 10-Q · filed 2011-11-04 | $25.97M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $12.90M 10-Q · filed 2011-08-08 | $18.11M 10-Q · filed 2011-08-08 | $20.95M derived: sum of 3 quarters · filed 2012-02-29 | $10.43M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $5.21M 10-Q · filed 2011-05-05 | $8.05M derived: sum of 2 quarters · filed 2012-02-29 | -$2.47M derived: sum of 3 quarters · filed 2012-02-29 | -$206.00K derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$7.68M derived: sum of 2 quarters · filed 2012-02-29 | -$5.42M derived: sum of 3 quarters · filed 2012-02-29 | -$2.62M 10-K · filed 2012-02-29 |
| 2009-09-30 | -$10.52M 10-Q · filed 2010-11-04 | -$8.26M derived: sum of 2 quarters · filed 2010-11-04 | -$5.46M 10-Q · filed 2010-11-04 | |
| 2009-06-30 | $2.27M 10-Q · filed 2010-08-05 | $5.06M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | -$62.91M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |